Literature DB >> 15562471

Improving the segmentation of therapy-induced leukoencephalopathy in children with acute lymphoblastic leukemia using a priori information and a gradient magnitude threshold.

John O Glass1, Wilburn E Reddick, Cara Reeves, Ching-Hon Pui.   

Abstract

Reliably quantifying therapy-induced leukoencephalopathy is a challenging task due to the similarity between its MR properties and those of normal tissues. Multispectral MR images were analyzed for 15 children treated for acute lymphoblastic leukemia. Three different analysis techniques were compared to examine improvements in the segmentation accuracy of leukoencephalopathy versus manual tracings by two experienced observers. The original technique used a white matter mask based on the segmentation of the first serial examination of each patient and no a priori information. The modified techniques combine spatially normalized a priori maps as input and a gradient magnitude threshold. The second technique used a 2D threshold, while the third algorithm utilized a 3D threshold. MR images were segmented with a Kohonen self-organizing map for all three algorithms. Kappa values were compared for the three techniques to each observer and statistically significant improvements were seen between the original and third algorithms (Observer 1: 0.651, 0.744, P = 0.015; Observer 2: 0.603, 0.699, P = 0.024). More accurate and reliable quantification reduces the amount of variance in MR measures and facilitates clinical trials to determine the clinical significance of leukoencephalopathy in this vulnerable population. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562471      PMCID: PMC2396882          DOI: 10.1002/mrm.20259

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  19 in total

1.  Nonlinear spatial normalization using basis functions.

Authors:  J Ashburner; K J Friston
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

2.  Utility of simultaneous brain, CSF and hyperintensity quantification in dementia.

Authors:  Richard H Swartz; Sandra E Black; Anthony Feinstein; Conrad Rockel; Gal Sela; Fu Qiang Gao; Curtis B Caldwell; Michael J Bronskill
Journal:  Psychiatry Res       Date:  2002-11-30       Impact factor: 3.222

3.  Generalized clustering networks and Kohonen's self-organizing scheme.

Authors:  N R Pal; J C Bezdek; E K Tsao
Journal:  IEEE Trans Neural Netw       Date:  1993

4.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

Authors:  D H Mahoney; J J Shuster; R Nitschke; S J Lauer; C P Steuber; N Winick; B Camitta
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

5.  Correspondence of closest gradient voxels--a robust registration algorithm.

Authors:  J L Ostuni; R L Levin; J A Frank; C DeCarli
Journal:  J Magn Reson Imaging       Date:  1997 Mar-Apr       Impact factor: 4.813

6.  Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.

Authors:  W E Evans; M V Relling; J H Rodman; W R Crom; J M Boyett; C H Pui
Journal:  N Engl J Med       Date:  1998-02-19       Impact factor: 91.245

7.  White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.

Authors:  E Pääkkö; A Harila-Saari; L Vanionpää; S Himanen; J Pyhtinen; M Lanning
Journal:  Med Pediatr Oncol       Date:  2000-11

8.  Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra- and inter-observer agreement variability: a comparison with manual contouring method.

Authors:  Roberto C Parodi; Francesco Sardanelli; Paolo Renzetti; Elisabetta Rosso; Caterina Losacco; Alessandra Ferrari; Fabrizio Levrero; Alberto Pilot; Matilde Inglese; Giovanni L Mancardi
Journal:  Eur Radiol       Date:  2001-07-24       Impact factor: 5.315

9.  Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI.

Authors:  Edward A Ashton; Chihiro Takahashi; Michel J Berg; Andrew Goodman; Saara Totterman; Sven Ekholm
Journal:  J Magn Reson Imaging       Date:  2003-03       Impact factor: 4.813

10.  Variability and validity of a simple visual rating scale in grading white matter changes on magnetic resonance imaging.

Authors:  Yu Hua Fan; Wynnie W M Lam; Vincent C T Mok; Ru Xun Huang; Ka Sing Wong
Journal:  J Neuroimaging       Date:  2003-07       Impact factor: 2.486

View more
  13 in total

1.  A novel, fast entropy-minimization algorithm for bias field correction in MR images.

Authors:  Qing Ji; John O Glass; Wilburn E Reddick
Journal:  Magn Reson Imaging       Date:  2006-11-13       Impact factor: 2.546

2.  A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.

Authors:  Wilburn E Reddick; John O Glass; Kathleen J Helton; James W Langston; Chin-Shang Li; Ching-Hon Pui
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

3.  Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate.

Authors:  John O Glass; Wilburn E Reddick; Chin-Shang Li; Fred H Laningham; Kathleen J Helton; Ching-Hon Pui
Journal:  Magn Reson Imaging       Date:  2006-04-27       Impact factor: 2.546

4.  Comparing segmented ASL perfusion of vascular territories using manual versus semiautomated techniques in children with sickle cell anemia.

Authors:  Kathleen J Helton; John O Glass; Wilburn E Reddick; Amir Paydar; Arash R Zandieh; Rachna Dave; Matthew P Smeltzer; Song Wu; Jane Hankins; Banu Aygun; Robert J Ogg
Journal:  J Magn Reson Imaging       Date:  2014-01-08       Impact factor: 4.813

Review 5.  Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.

Authors:  Wilburn E Reddick; John O Glass; Kathleen J Helton; James W Langston; Xiaoping Xiong; Shengjie Wu; Ching-Hon Pui
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

6.  Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy.

Authors:  Gregory T Armstrong; Wilburn E Reddick; Ronald C Petersen; Aimee Santucci; Nan Zhang; Deokumar Srivastava; Robert J Ogg; Claudia M Hillenbrand; Noah Sabin; Matthew J Krasin; Larry Kun; Ching-Hon Pui; Melissa M Hudson; Leslie L Robison; Kevin R Krull
Journal:  J Natl Cancer Inst       Date:  2013-04-12       Impact factor: 13.506

7.  The effects of propofol on cerebral perfusion MRI in children.

Authors:  Julie H Harreld; Kathleen J Helton; Roland N Kaddoum; Wilburn E Reddick; Yimei Li; John O Glass; Rakhee Sansgiri; Qing Ji; Tianshu Feng; Mary Edna Parish; Amar Gajjar; Zoltan Patay
Journal:  Neuroradiology       Date:  2013-05-15       Impact factor: 2.804

Review 8.  Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.

Authors:  Wilburn E Reddick; Fred H Laningham; John O Glass; Ching-Hon Pui
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

9.  Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia.

Authors:  Kathleen J Helton; Amir Paydar; John Glass; Eric M Weirich; Jane Hankins; Chin-Shang Li; Matthew P Smeltzer; Winfred C Wang; Russell E Ware; Robert J Ogg
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

10.  Elevated cerebral blood volume contributes to increased FLAIR signal in the cerebral sulci of propofol-sedated children.

Authors:  J H Harreld; N D Sabin; M G Rossi; R Awwad; W E Reddick; Y Yuan; J O Glass; Q Ji; A Gajjar; Z Patay
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.